AMERICAN OPIOIDS EPIDEMIC
With the onset of the New Year and the new decade ahead , I decided to do some light reading of health-related reports for the last twenty years, as well as projections for the coming decade. I happened across a report from Brookings. Its opening statement was pretty grim.
The United States is undoubtedly one of the most powerful, wealthiest, and most advanced countries in the world. And while we should always anticipate some shortcomings in even the greatest of nations, it comes as a surprise that the United States takes fifth place in the entire world for drug overdose deaths. The U.S. is ahead of almost all other developed nations for drug overdoses. The U.S. also loses more people per capita to drug overdoses than most third-world countries. How could this be?
When seeking to address the 21st-century addiction epidemic, one of the first lessons to learn is that this is not a new problem.
For decades, drug addiction has been a problem in the United States. We continuously see the daily headlines of terror and trauma relating to addiction. We are inclined to think that this is a new problem. In actual fact, this is not a new problem at all. There is just more of the problem.
The issue with opioid pain relievers has the appearance of one of those unsolvable paradoxes. If we reduce access to opioid pharmaceuticals considerably, patients who experience chronic and severe pain issues might not be able to access pain relief. But in that same token, if we continue to accept opioid pharmaceuticals as standard medical practice and utilize them to the degree that we are, millions of Americans will become addicted to them, and thousands will die from overdoses on them. That is the brutal truth of the matter.
For some time now we have known that our nation’s drug crisis will not resolve with only government action alone. It’s become apparent, now twenty years into the largest addiction epidemic that our country has likely ever seen, that curbing drug addiction within our communities will take community action, as well as federal and state support.
Let’s talk about one of the most controversial subjects in pharmaceutical prescribing. This is the current proposal for reducing opioid prescribing to curb the opioid epidemic.
In my morning reading, I happened across an article in U.S. News which discussed the disparity of the opioid crisis in America. The report, written by Robert Preidt, a HealthDay reporter, focused on the opioid turmoil as it has touched down in Indiana, Kentucky, Massachusetts, Maryland, Maine, New Hampshire, and Ohio.
I went a few years without listening to the radio. Premium memberships to online streaming stations, why bother? But a few days ago I was driving across the state, coincidentally through an internet dead zone.
According to The Associated Press , eleven “abuse-deterrent” opioid pain reliever drugs are available, with thirty more in development. Talk to any doctor in America today about pain relief, and odds are you’ll hear the phrase, “abuse-deterrent” more than once.